The largest database of trusted experimental protocols

Elecsys anti sars cov 2 s test

Manufactured by Roche
Sourced in Switzerland

The Elecsys® Anti-SARS-CoV-2 S test is a lab equipment product developed by Roche. It is an immunoassay used for the quantitative determination of antibodies to the SARS-CoV-2 spike (S) protein in human serum and plasma.

Automatically generated - may contain errors

6 protocols using elecsys anti sars cov 2 s test

1

SARS-CoV-2 Antibody Response Measurement

Check if the same lab product or an alternative is used in the 5 most similar protocols
The antibody response to SARS-CoV-2 S protein was measured using the Elecsys® Anti-SARS-CoV-2 S test (quantitative), while the antibody response to SARS-CoV-2 N protein was measured using the Elecsys® Anti-SARS-CoV-2 IgM/IgA/IgG test (Roche Diagnostics International Ltd., Rotkreuz, Switzerland, semi-quantitative) according to the manufacturer’s instructions. A lack of response to the N-protein was defined at anti-N protein antibody titers lower than one.
+ Open protocol
+ Expand
2

Quantifying SARS-CoV-2 Antibody Responses

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibody response to SARS-CoV-2 S protein was measured using the Elecsys® Anti-SARS-CoV-2 S test (quantitative), while antibody response to SARS-CoV-2 N protein was measured using the Elecsys® Anti-SARS-CoV-2 IgM/IgA/IgG test (Roche Diagnostics International Ltd., Rotkreuz, Switzerland, semiquantitative) according to the manufacturer's instructions. Lack of response to the N protein was defined at anti-N protein antibody titers lower than one. The titers of anti-S protein antibodies have an upper limit of 25,000 BAU/mL since the last dilution performed in the routine analysis is 1/100; samples with titers higher than 25,000 BAU/mL have been assigned 25,000 BAU/mL.
+ Open protocol
+ Expand
3

Serological Assay for SARS-CoV-2 Antibodies

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Elecsys Anti-SARS-CoV-2 S test (Roche Diagnostics GmbH) [14 ] detecting complete Ig directed to Spike-(S) protein receptor-binding-domain (RBD) was operated on the COBAS pro e 801 module according to the manufacturer’s recommendations. Cutoff values were chosen as specified by the manufacturer. Test characteristics are shown in Table 1.
+ Open protocol
+ Expand
4

Quantitative Antibody Detection in SARS-CoV-2

Check if the same lab product or an alternative is used in the 5 most similar protocols
Serum samples were analyzed for detection of antibodies to SARS-CoV-2 spike using the quantitative Elecsys® Anti-SARS-CoV-2 S test (Roche Diagnostics) (25 (link)) on the Cobas 8000 e801pro. The measuring range was between 0.40 to 250 U/mL, and the cut-off value for positive results is ≥ 0.80 U/mL Positive samples with antibody titers of >250 U/mL were re-tested following 1/10 dilution, and in some cases 1/100 dilution with the upper level of measuring range 25,000 U/mL.
+ Open protocol
+ Expand
5

Serological Assessment of SARS-CoV-2 Antibodies

Check if the same lab product or an alternative is used in the 5 most similar protocols
Elecsys Anti-SARS-CoV-2 S test (Roche Diagnostics, Rotkreuz, Switzerland) was used to test for SARS-CoV-2 IgG/total antibodies. This immunoassay targets antibodies against the viral spikes protein, specifically its receptor-binding domain (RBD), a common target for virus-neutralizing antibodies and the focus of therapeutics and vaccine design. After the 5 ml of blood was obtained from each participant, it was placed into serum separator tubes and allowed to coagulate at room temperature for 60 min. It was then stored at 4 °C until centrifugation. The serum was then analyzed according to the manufacturer’s recommendations.
+ Open protocol
+ Expand
6

Antibody Response to SARS-CoV-2 Vaccines in Rheumatic Diseases

Check if the same lab product or an alternative is used in the 5 most similar protocols
We collected various demographic and clinical information: from the subjects, including age, sex, type of vaccine received (BNT162b2 or mRNA-1237), dates of vaccination (second and third doses), dates of sample extraction, specific rheumatic disease, treatment regimen for the disease, and information on current glucocorticoid use as a binary variable.
Antibodies against S and N SARS-CoV-2 protein
Antibody response to SARS-CoV-2 S protein was measured using the Elecsys® Anti-SARS-CoV-2 S test (Roche Diagnostics International Ltd, Rotkreuz, Switzerland, quantitative) according to manufacture instructions. In these experiments, the standards and international units proposed by the WHO for the determination of antibodies against SARS-CoV-2 (Binding Antibody Units, BAU/ml) [22 (link)] were used. Based on previous studies [23 (link)], a value of 260 has been established as the minimum to consider the presence of a protective level against SARS-CoV-2 and, therefore, the minimum value to consider a patient as a responder to the vaccine.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!